Clinical trial

To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years

Invitation only · Not applicable · 1 countries · Registry ID NCT07387393

Invitation onlyNot applicableInterventional

What this study is about

In this study, the investigators are conducting a Type 3 hybrid effectiveness-implementation trial to evaluate the implementation of the Community Health Workers (CHW)-delivered PILI Pasifika Program (PPP) across 3 regions, the U.S. Affiliated Pacific Islands (USAPI), the continental U.S., and Hawai'i, among 400 Native Hawaiian and Pacific Islander (NHPI) participants in two settings, (clinical and non-clinical) over a 3-year period. The PPP is a 3-month lifestyle intervention that includes a Social Determinants of Health (SDOH) component and was NHPI-adapted from the Diabetes Prevention Program's Lifestyle Program, renamed to the PILI Lifestyle Program (PLP), which demonstrated effectiveness in improving weight, blood pressure, physical activity, and diet among NHPIs. The PPP consists of 8 lifestyle lessons and 4 SDOH activities delivered over a 3-month period. The aims of this study are threefold: 1. To evaluate the implementation of the PPP across multiple community sites using a Type 3 hybrid effectiveness-implementation design guided by established frameworks such as RE-AIM and PRISM. 2. To examine participant-level outcomes associated with PPP implementation, including changes in cardiometabolic risk factors, health behaviors, and SDOH factors from baseline to 3 and 9-month follow-up. 3. To evaluate the cost and cost-effectiveness of implementing the PPP across community settings.

A promising-looking record is not the same as confirmed eligibility. The study team must review the full criteria and current recruitment status.

Basic eligibility

Age18 Years to Not listed
SexAll
Healthy volunteersNot accepted
ConditionCardiometabolic Conditions, Hypertension (HTN), Dyslipidemia, Pre-diabetes, Type 2 Diabetes Mellitus (T2DM), Overweight (BMI > 25), Weight Loss Trial

Full registry criteria

Inclusion Criteria: * Self-identify as Native Hawaiian or Pacific Islander * 18 years of age or older * Have at least one of the following self-reported cardiometabolic conditions (Overweight or obesity defined as BMI ≥ 25, pre-diabetes or diabetes, high blood pressure, and/or high cholesterol) * Able to do a moderate level of physical activity or exercise Exclusion Criteria: * Do not identify as Native Hawaiian or Pacific Islander * Under 18 years of age * Currently a student * Do not have any of the following conditions (overweight/obesity, pre-diabetes/diabetes, high blood pressure, or high cholesterol) * Have special dietary needs/dietary restrictions (due to cultural reasons and/or told by a healthcare provider) * Pregnant women * Have physical activity limitations/restrictions (told by a healthcare provider)

Treatments and study arms

PILI (Partnership for Improving Lifestyle Intervention) Pasifika Program

Behavioral

The PILI Pasifika Program (PPP) is an adapted 3-month behavioral lifestyle intervention with an enhanced social determinants of health (SDOH) component focused on initiating weight loss and addressing social and cultural challenges, such as access to healthy foods, housing, and employment issues, among Native Hawaiians and Pacific Islanders (NHPIs). The 3-month PPP includes 8 lessons that offer empirically supported strategies (e.g., plate method, stimulus control), grounded in Social Cognitive Theory, to improve healthy eating, physical activity, and time and stress management, as well as 4 SDOH activities that guide community needs, such as food access, transportation, and housing throughout the program.

Primary outcomes

Hemoglobin A1CAssessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

A finger stick sample will be collected to measure hemoglobin A1C using the A1CNow+ kit.

Lipid PanelAssessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

A fingerstick sample will be collected to measure Total Cholesterol, High-Density Lipoprotein (HDL), Low-Density Lipoprotein (LDL), and Triglycerides using the CardioChek Plus Analyzer.

Blood PressureAssessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

Systolic and diastolic blood pressure will both be measured by a digital blood pressure monitor device (Omron HEM-907XL IntelliSense).

WeightAssessment data will be collected at baseline, 3-month follow-up, and 9-month follow-up.

Weight will be calculated using a standardized mobile medical flat scale (Seca 876).

Body Mass Index (BMI)Assessment data will be collected at baseline and 3-month follow-up.

Height data will be measured at baseline using a standardized portable stadiometer. Weight will be measured using a standardized mobile medical flat scale. BMI will be calculated.

Study locations

2 locations were listed when this page was built. The first 40 are shown.

National Association of Pasifika Organizations🇺🇸 Fayetteville, Arkansas, United States
Papa Ola Lokahi🇺🇸 Honolulu, Hawaii, United States